Swiss National Bank Grows Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Share on StockTwits

Swiss National Bank raised its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 2.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 110,400 shares of the company’s stock after buying an additional 2,300 shares during the quarter. Swiss National Bank’s holdings in Molina Healthcare were worth $15,803,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Iridian Asset Management LLC CT raised its stake in Molina Healthcare by 7.7% in the first quarter. Iridian Asset Management LLC CT now owns 1,139,103 shares of the company’s stock valued at $161,707,000 after buying an additional 81,120 shares during the last quarter. Geode Capital Management LLC raised its stake in Molina Healthcare by 5.3% in the fourth quarter. Geode Capital Management LLC now owns 586,758 shares of the company’s stock valued at $68,192,000 after buying an additional 29,687 shares during the last quarter. Clark Capital Management Group Inc. purchased a new stake in Molina Healthcare in the second quarter valued at about $739,000. Dimensional Fund Advisors LP raised its stake in Molina Healthcare by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 610,075 shares of the company’s stock valued at $70,899,000 after buying an additional 25,932 shares during the last quarter. Finally, Dupont Capital Management Corp raised its stake in Molina Healthcare by 10.1% in the first quarter. Dupont Capital Management Corp now owns 9,104 shares of the company’s stock valued at $1,292,000 after buying an additional 835 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

MOH has been the subject of a number of research analyst reports. Bank of America reiterated an “underperform” rating and issued a $140.00 price target (up from $132.00) on shares of Molina Healthcare in a research note on Wednesday, July 31st. Wells Fargo & Co upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating and set a $177.00 price target for the company in a research note on Friday, May 31st. Stephens set a $150.00 price target on Molina Healthcare and gave the company a “hold” rating in a research note on Wednesday, August 7th. BMO Capital Markets upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating and increased their price target for the company from $154.00 to $200.00 in a research note on Monday, June 3rd. Finally, ValuEngine upgraded Molina Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $162.27.

In other news, Director Garrey Carruthers sold 1,300 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $152.75, for a total value of $198,575.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Daniel Cooperman sold 4,004 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $155.00, for a total value of $620,620.00. Following the completion of the transaction, the director now owns 4,096 shares of the company’s stock, valued at $634,880. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,679 shares of company stock valued at $868,556. Company insiders own 0.77% of the company’s stock.

Shares of NYSE:MOH opened at $127.33 on Friday. Molina Healthcare, Inc. has a 52-week low of $105.28 and a 52-week high of $159.00. The stock has a market cap of $8.34 billion, a price-to-earnings ratio of 11.49, a PEG ratio of 1.22 and a beta of 1.25. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.85. The business has a 50-day moving average price of $137.00 and a 200-day moving average price of $137.40.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $3.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.56 by $0.55. Molina Healthcare had a return on equity of 51.49% and a net margin of 4.48%. The firm had revenue of $4.19 billion during the quarter, compared to analysts’ expectations of $4.08 billion. During the same period last year, the business posted $3.08 earnings per share. The company’s revenue for the quarter was down 14.1% compared to the same quarter last year. As a group, equities analysts anticipate that Molina Healthcare, Inc. will post 11.38 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

See Also: 52-Week High/Low

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

CorMedix  Raised to “Hold” at Zacks Investment Research
CorMedix Raised to “Hold” at Zacks Investment Research
Artesian Resources Co.  Short Interest Up 10.5% in August
Artesian Resources Co. Short Interest Up 10.5% in August
GN STORE NORD A/ADR  Cut to Hold at Zacks Investment Research
GN STORE NORD A/ADR Cut to Hold at Zacks Investment Research
Gildan Activewear  Upgraded by Zacks Investment Research to “Buy”
Gildan Activewear Upgraded by Zacks Investment Research to “Buy”
Arts-Way Manufacturing Co. Inc.  Short Interest Down 5.3% in August
Arts-Way Manufacturing Co. Inc. Short Interest Down 5.3% in August
GMS  Raised to Buy at Zacks Investment Research
GMS Raised to Buy at Zacks Investment Research


© 2006-2019 Ticker Report